Table 2.
Effect | Category of interest versus reference category | Point estimate of the odds ratio | 95% confidence interval (Wald’s type) |
---|---|---|---|
A. Effects of age, gender and/or CIRS-G score-related comorbidity index on ACB score | |||
Sex | Female vs. male | 0.72 | [0.55; 0.94] |
Age class | 75 years to < 85 years vs. 65 years to < 75 years | 1.13 | [0.85; 1.50] |
≥ 85 years vs. 65 years to < 75 years | 1.79 | [1.08; 2.94] | |
CMI (4 classes) | Quartile 2 CMI 3–4 vs. Quartile 1 CMI 0–2 | 1.69 | [1.13; 2.52] |
Quartile 3 CMI 5–7 vs. Quartile 1 CMI 0–2 | 2.03 | [1.38; 2.99] | |
Quartile 4 CMI ≥ 8 vs. Quartile 1 CMI 0–2 | 3.29 | [2.23; 4.86] | |
B. Effects of age and/or gender on the comorbidity index | |||
Sex | Female vs. male | 0.57 | [0.44; 0.74] |
Age class | 75 years to < 85 years vs. 65 years to < 75 years | 2.28 | [1.74; 2.99] |
≥ 85 years vs. 65 years to < 75 years | 2.79 | [1.73; 4.51] |
Odds ratio point estimates and confidence intervals calculated by comparing the respective category of interest with the reference category for the possible explanatory variables included in the model for the likelihood of having an anticholinergic burden (A) or a comorbidity index of > 4 (B)